BCRX
#1876
BioCryst Pharmaceuticals, Inc. - Common Stock
9.4 1 USD
-0.03%
Sector: Healthcare
Base: USD
Profit Currency: USD
Daily Range
Year Range
Daily Change
-3.39%
Monthly Change
+3.52%
6 month change
+32.16%
Year Change
+7.54%
Previous Close
9.7 4
Open
9.4 1
Low
9.4 1
High
9.4 1
Volume
158
Financials
- Market Capitalization 2.39 B
- Employee 435
- Founded 1986
- CEO Jon P. Stonehouse
- Website www.biocryst.com
- Headquarter Delaware, United States
- FIGI BBG000BLYWX6
- Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-5.38
Price to sales ratio
2.4
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 1862 |  NRIX Nurix Therapeutics, Inc. - Common stock | 23.85 USD | +3.79% | -0.58% | +40.87% | +112.76% | 2.48 B USD | ||
| 1864 |  TARS Tarsus Pharmaceuticals, Inc. - Common Stock | 57.50 USD | +2.48% | -14.23% | -7.45% | -12.96% | 2.47 B USD | ||
| 1877 |  VCEL Vericel Corporation - Common Stock | 46.72 USD | +1.37% | -1.56% | +21.60% | +28.53% | 2.39 B USD | ||
| 1879 |  SLS SELLAS Life Sciences Group, Inc. - Common Stock | 12.79 USD | -4.48% | -7.05% | +68.29% | +566.15% | 2.38 B USD |
Frequently asked questions about BioCryst Pharmaceuticals, Inc. - Common Stock
What is the BioCryst Pharmaceuticals, Inc. - Common Stock stock price today?
The current price of BioCryst Pharmaceuticals, Inc. - Common Stock (BCRX) is 9.41. Over the past 24 hours, the stock has changed by -3.39%. Follow the BCRX chart for real-time price dynamics.
What is the stock ticker of BioCryst Pharmaceuticals, Inc. - Common Stock?
BioCryst Pharmaceuticals, Inc. - Common Stock trades under the ticker BCRX. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is BioCryst Pharmaceuticals, Inc. - Common Stock stock going up?
BCRX has changed by -15.61% over the last week, +3.52% over the last month, and +7.54% over the last year. Review the chart to see whether the current move is part of a broader trend.
What was BioCryst Pharmaceuticals, Inc. - Common Stock net income for the last quarter?
BioCryst Pharmaceuticals, Inc. - Common Stock reported net income of -721.81 M for the last quarter. The previous quarter showed 245.84 M, which means net income changed by -393.60%.
How many employees does BioCryst Pharmaceuticals, Inc. - Common Stock have?
As of the latest available data, BioCryst Pharmaceuticals, Inc. - Common Stock has 435 employees. Workforce size can provide additional context about the company's scale and operations.
What is BioCryst Pharmaceuticals, Inc. - Common Stock EBITDA?
BioCryst Pharmaceuticals, Inc. - Common Stock EBITDA is -700.16 M, and its EBITDA margin is -447.64%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy BioCryst Pharmaceuticals, Inc. - Common Stock stock?
You can buy BioCryst Pharmaceuticals, Inc. - Common Stock (BCRX) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in BioCryst Pharmaceuticals, Inc. - Common Stock stock?
Investing in BioCryst Pharmaceuticals, Inc. - Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the BCRX chart and related analysis on metatrader.com as part of your research.